
Ladenburg Thalmann gives a Buy recommendation for Cellectar Biosciences Inc (CLRB)
Cellectar Biosciences Inc’s recent filing unveils that its Chief Operating Officer Longcor Jarrod acquired Company’s shares for reported $8400.0 on
Cellectar Biosciences Inc’s recent filing unveils that its Chief Operating Officer Longcor Jarrod acquired Company’s shares for reported $8400.0 on
Cellectar Biosciences Inc’s filing revealed that its Chief Operating Officer Longcor Jarrod acquired Company’s shares for reported $8400.0 on Jan
Cellectar Biosciences Inc’s filing revealed that its Chief Operating Officer Longcor Jarrod acquired Company’s shares for reported $8400.0 on Jan
Cellectar Biosciences Inc’s filing revealed that its Chief Operating Officer Longcor Jarrod acquired Company’s shares for reported $8400.0 on Jan
Cellectar Biosciences Inc’s recent filing unveils that its Chief Operating Officer Longcor Jarrod acquired Company’s shares for reported $8400.0 on
Cellectar Biosciences Inc’s filing revealed that its Chief Operating Officer Longcor Jarrod acquired Company’s shares for reported $8400.0 on Jan
Cellectar Biosciences Inc’s filing revealed that its Chief Operating Officer Longcor Jarrod acquired Company’s shares for reported $8400.0 on Jan